Searched for
CHRONIC ILLNESS DRUGS
Home nursing, oxygen, physio - health insurance covers only 60–180 days after hospitalisation; here’s how to plan the restHome nursing, physiotherapy, oxygen support—health insurance can cover these for 60-180 days after discharge, with conditions. The rest of ...06 Apr, 2026, 10.46 AM IST- Did Lamar Odom die? Here’s why the story is taking the internet by stormLamar Odom death: Lamar Odom is back in global headlines following the release of Netflix’s documentary Untold: The Death & Life of Lamar O...31 Mar, 2026, 09.49 PM IST
- New survey reveals chronic fatigue syndrome is not rare, affects 3.3 mn adultsThe report challenges the perception of CFS as a rare illness, emphasising its impact on a broader population.09 Dec, 2023, 03.32 PM IST
- Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MDAlkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and co...06 Jun, 2023, 10.05 AM IST
- Alkem Labs to grow chronic therapies to drive future growth: MDThe Mumbai-based drug maker, which entered the US generics market over a decade ago, is also scaling back its investments in oral solids in...06 Jun, 2023, 12.42 AM IST
- Zydus Cadila files investigational new drug application for COVID-19 treatmentDrug firm Zydus Cadila on Tuesday said it has filed the investigational new drug (IND) application for ZYIL1, positioned for management of ...03 Nov, 2020, 12.44 PM IST
- Biocon’s biosimilar for treating Covid-19: Patients responded positively, says Kiran Mazumdar-ShawThe Drug Controller General of India (DGCI) has permitted the Bengaluru-headquartered drug maker to market Itolizumab (ALZUMab) injection 2...12 Jul, 2020, 02.55 PM IST
- Wockhardt rallies after revival plan gets a boost from drug nodInvestors cheered the news, sending Wockhardt’s shares up by 5.7 per cent on the BSE on Thursday.17 Jan, 2020, 08.37 AM IST
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...08 Dec, 2017, 09.45 PM IST
- Content platform aimed at reversing chronic illnesses, Sepalika, raises $750,000 from AccelThe platform aims to use the fresh capital infused for further building on its research-based content and strengthening its core propositio...28 Apr, 2017, 05.16 PM IST
- Biologics enter top selling drugs’ listBiologics, also called biopharmaceuticals, have revolutionised treatment in chronic and serious illnesse and nudged traditional drugs out o...28 Dec, 2016, 11.55 AM IST
- Demonetisation: People stock up on medicines to get rid of old notesAWACs found that anti-diabetic, cardiovascular and BP drugs have shown a significant increase in sales as compared to corresponding period ...29 Nov, 2016, 12.58 AM IST
- Revision in National List of Essential Medicines to help save up to 20%The overall coverage of new medicines being added to the NLEM will be nearly Rs 8,000 crore in the organized pharma retail market.31 Dec, 2015, 01.12 PM IST
- Chronic illness sees a spurt in business opportunity for pharma marketAccording to data from AIOCD, the Indian pharma market has grown at a compound annual growth rate of 3.3% in volume terms in the past five ...19 Nov, 2014, 05.42 AM IST
- Slowdown bout forces people to trim medical billsPeople have been popping fewer pills, reducing their visits to the doctor and going as far as discontinuing treatment when there is the sli...17 Mar, 2009, 12.52 AM IST
- Novartis to buy Nektar's pulmonary unit for $115MPharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for US$115 millio...21 Oct, 2008, 03.16 PM IST
- Bitter sweet: India sees 17% rise in sale of diabetic medicinesIndia, which is home to the largest diabetic population in the world, has recorded a 17% rise in the anti-diabetic drug segment.18 Oct, 2008, 12.41 AM IST
Load More
